Hannover Clinical Trial Center (Germany)

Early detection of diabetic kidney disease by urinary proteomics and subsequent intervention with spironolactone to delay progression (PRIORITY): a prospective observational study and embedded randomised placebo-controlled trial

Nete Tofte, Morten Lindhardt, Katarina Adamova et al. · The Lancet Diabetes & Endocrinology · 2020 · 247 citations · Full text

Urology, Renal Disease, Renal Function +8

Peginterferon alfa-2a plus tenofovir disoproxil fumarate for hepatitis D (HIDIT-II): a randomised, placebo controlled, phase 2 trial

Heiner Wedemeyer, Cihan Yurdaydın, Svenja Hardtke et al. · The Lancet Infectious Diseases · 2019 · 185 citations

Hepatitis D, Hepatology, Viral Hepatitis +8

Ledipasvir plus sofosbuvir fixed-dose combination for 6 weeks in patients with acute hepatitis C virus genotype 1 monoinfection (HepNet Acute HCV IV): an open-label, single-arm, phase 2 study

Katja Deterding, Christoph D. Spinner, Eckart Schott et al. · The Lancet Infectious Diseases · 2016 · 129 citations

Hepatology, Hepatitis C, Viral Hepatitis +8

Proteomic prediction and Renin angiotensin aldosterone system Inhibition prevention Of early diabetic nephRopathy in TYpe 2 diabetic patients with normoalbuminuria (PRIORITY): essential study design and rationale of a randomised clinical multicentre trial

Morten Lindhardt, Frederik Persson, Gemma Currie et al. · BMJ Open · 2016 · 122 citations · Full text

Multicentre prospective validation of a urinary peptidome-based classifier for the diagnosis of type 2 diabetic nephropathy

Justyna Siwy, Joost P. Schanstra, Àngel Argilés et al. · Nephrology Dialysis Transplantation · 2014 · 111 citations · Full text